Indoramin Increase Tops UK Rises In September
Pricewatch UK – September 2021
Benign prostatic hyperplasia treatment indoramin topped the UK’s steepest generic price rises in September with an average price that more than trebled, according to the latest figures from WaveData.
You may also be interested in...
Two generics saw their average UK trade prices almost double in October for very different reasons, according to the latest pricing information from market researcher WaveData.
Timolol eye drops saw their prices leap in August while sildenafil’s slide saw prices cut in half, according to the latest UK generics pricing figures from WaveData.
Ivabradine exhibited interesting pricing dynamics in the UK in June, with the average cost of the heart failure treatment more than trebling despite the lowest offer in the market remaining stable.